GlassScriptPhysician profile
Andrew Dudas
NPI 1093245722
$26,954.63
in general payments reported to CMS, 2019-2025
24 companies · $2,894 in 2025
The $2,894 reported for 2025 was more than what 88% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,179 · 2022: $5,587 · 2023: $11K · 2024: $4,196 · 2025: $2,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,302.13 |
| Travel and Lodging | $4,886.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,857.73 | 2021-2025 | Proclaim, Eterna, Infinity |
| Medtronic, INC. | $3,135.14 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Nevro Corp. | $3,015.39 | 2021-2024 | Senza |
| Boston Scientific Corporation | $1,595.57 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Globus Medical, INC. | $419.44 | 2025 | Senza, Vyrsa V1 |
| Saluda Medical Americas, INC. | $324.44 | 2025 | Evoke |
| Protega Pharmaceutials INC | $289.44 | 2024-2025 | Roxybond |
| Clariance Sas | $188.33 | 2024 | |
| Pfizer INC. | $163.35 | 2023-2025 | |
| Relievant Medsystems, INC. | $162.26 | 2022-2023 | Intracept |
| Scilex Pharmaceuticals INC. | $150.66 | 2023-2024 | Ztlido |
| Spr Therapeutics, INC | $122.14 | 2022-2025 | Sprint Pns System |
| Curonix LLC | $100.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceutical Holding Company LTD. | $86.20 | 2022 | |
| Nalu Medical, INC. | $76.08 | 2023 | Nalu Neurostimulation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $58.00 | 2022 | |
| Averitas Pharma INC. | $45.97 | 2023-2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $30.60 | 2022-2023 | Belbuca |
| Stryker Corporation | $29.32 | 2025 | Mild Device Kit |
| Abbvie INC. | $25.91 | 2023 | Ubrelvy, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.34 | 2025 | Relistor |
| Vertos Medical, INC. | $22.25 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.40 | 2025 | |
| Lilly USA, LLC | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dudas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.